Bristol Myers Squibb - News
WEBStay updated on the latest news from Bristol Myers Squibb, a global biopharmaceutical company dedicated to developing and delivering innovative medicines for serious diseases.
FDA approves Bristol Myers Squibb's schizophrenia drug
WEBSep 26, 2024 · The Food and Drug Administration approved Bristol Myers Squibb’s highly anticipated schizophrenia drug, the first novel type of treatment for the debilitating, chronic mental disorder in more ...
Bristol Myers Squibb - News
WEBSep 18, 2024 · Bristol Myers Squibb to Present Data at ESMO Demonstrating Ongoing Leadership in Immuno-Oncology and Progression of Assets from Its Differentiated Research Platforms
Bristol Myers Squibb - Bristol Myers Squibb Presents New …
WEBApr 6, 2024 · PRINCETON, N.J.--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) today announced interim long-term safety, tolerability and metabolic outcomes data from its Phase 3 EMERGENT program evaluating KarXT (xanomeline-trospium) in adults with schizophrenia. These data were presented in a poster titled, “Long-Term Safety of KarXT (Xanomeline and Trospium) in Schizophrenia” (Poster F74) and in ...
Bristol Myers Squibb Presents New Data from Two Trials …
WEBSep 27, 2024 · About Bristol Myers Squibb. Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over ...
Bristol Myers to Acquire the Drugmaker Karuna for $14 Billion
WEBDec 22, 2023 · Bristol Myers Squibb, the global pharmaceutical giant, said on Friday that it would acquire Karuna Therapeutics, which makes drugs to treat schizophrenia and Alzheimer’s, in an all-cash deal...
Prime Medicine Inks Cell Therapy Pact With Bristol Myers Squibb …
WEB3 days ago · With the $110 million upfront consideration received from Bristol Myers Squibb under the strategic research collaboration and license agreement announced this morning, Prime Medicine expects its ...
Pharmaceutical press releases & news - Bristol Myers Squibb
WEBExplore Bristol Myers Squibb's latest press releases to learn more about our company, our medicines and research innovation, our partnerships, our people, and our Foundation efforts as we work to support patients fighting serious disease.
Bristol Myers Squibb Announces U.S. FDA Breakthrough Therapy ...
WEBOct 24, 2023 · PRINCETON, N.J.-- (BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for...
Bristol Myers beats $6.4 billion lawsuit over delayed cancer drug
WEB3 days ago · Sept 30 (Reuters) - Bristol Myers Squibb (BMY.N) won the dismissal on Monday of a $6.4 billion lawsuit claiming it cheated former Celgene shareholders by delaying federal approval for the cancer ...